ブロメラインの市場規模、シェア、成長分析、供給源別、種類別、形態別、酵素強度別、用途別、地域別 - 産業予測、2024年～2031年

ブロメラインの世界市場規模は、2022年に262億米ドルと評価され、2023年の280億米ドルから2031年には478億米ドルに成長し、予測期間中（2024年～2031年）のCAGRは6.9%で成長する見通しです。

ブロメラインの世界需要は、ヘルスケアと栄養補助食品分野における研究開発の活発化によって急増すると予測されます。ブロメラインには多くの健康上の利点があり、特に抗炎症作用や様々な症状に対する有効性がその魅力を大きく高めています。米国は、健康とウェルネスを重視する消費者層に後押しされ、北米の売上高の91％以上を占める圧倒的な市場となっています。アメリカの消費者は、高い自己認識と購買力を反映し、栄養補助食品を優先しています。栄養補助食品は世界売上の7%に過ぎないが、健康への応用を考えると、ブロメラインへのニーズは依然として高いです。ブロメライン市場は、主要企業がタイやフィリピンなどの熱帯諸国に集中している一方、研究開発は先進国で活発に行われており、製品の革新性と品質を高めています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別の機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主な市場の考察

• 主要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩
• 規制情勢
• ケーススタディ
• 特許分析

ブロメラインの市場規模：供給源別 & CAGR（2024年～2031年）

• 市場概要
• 幹
• 果物

ブロメラインの市場規模：形態別 & CAGR（2024年～2031年）

• 市場概要
• 粉末
• 液体

ブロメラインの市場規模：種類別 & CAGR（2024年～2031年）

• 市場概要
• 1200 GUD/g
• 2000 GUD/g
• 2500 GUD/g
• その他

ブロメラインの市場規模：酵素強度別 & CAGR（2024年～2031年）

• 市場概要
• 低い
• 高い
• 中程度

ブロメラインの市場規模：用途別 & CAGR（2024年～2031年）

• 市場概要
• 食品・飲料
• 栄養補助食品
• 製薬
• 化粧品・パーソナルケア
• その他

ブロメラインの市場規模 & CAGR（2024年～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021年～2023年）

主要企業プロファイル

• Advanced Enzyme Technologies（インド）
• Bio-gen Extracts Private Limited（インド）
• Creative Enzymes（米国）
• Enzybel International（Floridienne S.A.）（ベルギー）
• Enzyme Development Corporation（米国）
• Hong Mao Biochemicals Co., Ltd.（中国）
• Mitushi Biopharma（インド）
• Xena Bio Herbals Pvt. Ltd.（インド）
• Digestive Enzymes International Ltd.（米国）
• Nature's Sunshine Products（米国）
• Mountain Fresh Inc.（米国）
• Biozyme Laboratories（米国）
• Guangxi Nanning Javely Biological Products Co., Ltd.（中国）
• Nanning Doing-Higher Bio-Tech Co., Ltd.（中国）
• Xian Yuensun Biological Technology Co., Ltd.（中国）
• Botanic Healthcare（インド）
• Plamed Green Science Group（中国）
• Dayang Chem（Hangzhou）Co., Ltd.（中国）
• Integrative Therapeutics, Inc.（米国）
• Undersun Biomedtech Co., Ltd.（中国）

結論と推奨事項

Global Bromelain Market size was valued at USD 26.2 billion in 2022 and is poised to grow from USD 28 billion in 2023 to USD 47.8 billion by 2031, growing at a CAGR of 6.9% during the forecast period (2024-2031).

The global demand for bromelain is projected to surge, driven by increased R&D in the healthcare and dietary supplement sectors. The compound's numerous health benefits, particularly its anti-inflammatory properties and efficacy in treating various conditions, significantly boost its appeal. The United States represents a dominant market, contributing over 91% of North America's revenue, fueled by a consumer base that values health and wellness. American consumers prioritize dietary supplements, reflecting high self-awareness and purchasing power. Despite dietary supplements accounting for only 7% of global revenue, the need for bromelain remains pronounced, given its health applications. The bromelain market is concentrated, with key players located in tropical countries like Thailand and the Philippines, while R&D remains strong in developed nations, enhancing product innovation and quality.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bromelain market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bromelain Market Segmental Analysis

Global Bromelain Market is segmented by Source, Type, Form, Enzyme Strength, Application and Region. Based on Source, the market is segmented into Stem and Fruits. Based on Type, the market is segmented into 1200 GUD/g, 2000 GUD/g, 2500 GUD/g, Others. Based on Form, the market is segmented into Powered, Liquid. Based on Enzyme Strength, the market is segmented into Low, Medium, High. Based on Application, the market is segmented into Food and Beverages, Nutraceuticals, Pharmaceuticals, Cosmetics and Personal Care, Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bromelain Market

The global bromelain market is primarily driven by the increasing need for meat tenderizers, which significantly contributes to its growth. With its natural digestive and anti-inflammatory properties, bromelain has become a popular ingredient in dietary supplements. As more consumers become aware of the advantages associated with natural health products, the demand for bromelain is expected to rise considerably. This growing awareness of the health benefits linked to bromelain not only enhances its appeal in the wellness sector but also underlines its potential as a meat tenderizing agent, further fueling market expansion in various applications.

Restraints in the Global Bromelain Market

One of the significant constraints facing the global bromelain market is the limited availability of raw materials. Bromelain is derived from pineapples, and any disruptions in the supply chain or variations in pineapple yields can severely impact production levels. This scarcity of raw materials not only hampers the ability of manufacturers to meet increasing demand but also poses challenges in maintaining consistent quality and pricing of bromelain. Consequently, the restricted supply of pineapples can hinder the overall growth and expansion of the bromelain market, limiting opportunities for key players to innovate and develop new applications for this enzyme.

Market Trends of the Global Bromelain Market

The Global Bromelain market is experiencing a notable upward trend propelled by an increasing consumer preference for natural and organic health products. As awareness of the health benefits associated with bromelain, such as its anti-inflammatory and digestive enzyme properties, grows, demand for bromelain supplements is surging, particularly in the healthcare sector. This trend is further supported by a rising incidence of conditions like osteoarthritis, sinusitis, and gastrointestinal disorders, where bromelain is recognized for its therapeutic potential. Additionally, the expansion of e-commerce platforms and dietary supplement markets is facilitating greater accessibility, likely driving robust market growth in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Patent Analysis

Bromelain Market Size by Source & CAGR (2024-2031)

• Market Overview
• Stem
• Fruits

Bromelain Market Size by Form & CAGR (2024-2031)

• Market Overview
• Powdered
• Liquid

Bromelain Market Size by Type & CAGR (2024-2031)

• Market Overview
• 1200 GUD/g
• 2000 GUD/g
• 2500 GUD/g
• Others

Bromelain Market Size by Enzyme Strength & CAGR (2024-2031)

• Market Overview
• Low
• High
• Medium

Bromelain Market Size by Application & CAGR (2024-2031)

• Market Overview
• Food and Beverages
• Nutraceuticals
• Pharmaceutical
• Cosmetics and Personal Care
• Others

Bromelain Market Size & CAGR (2024-2031)

• North America (Source, Form, Type, Enzyme Strength, Application)
  • US
  • Canada
• Europe (Source, Form, Type, Enzyme Strength, Application)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Source, Form, Type, Enzyme Strength, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Source, Form, Type, Enzyme Strength, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Source, Form, Type, Enzyme Strength, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Advanced Enzyme Technologies (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-gen Extracts Private Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Enzymes (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzybel International (Floridienne S.A.) (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzyme Development Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hong Mao Biochemicals Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitushi Biopharma (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xena Bio Herbals Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Digestive Enzymes International Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nature's Sunshine Products (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mountain Fresh Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biozyme Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guangxi Nanning Javely Biological Products Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nanning Doing-Higher Bio-Tech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xian Yuensun Biological Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Botanic Healthcare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Plamed Green Science Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dayang Chem (Hangzhou) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrative Therapeutics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Undersun Biomedtech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation